上海医药集团股份有限公司 关于2019年A股股票期权激励计划 预留股票期权第三个行权期限制行权期间的提示性公告

Core Viewpoint - The announcement details the third exercise period for the stock option incentive plan of Shanghai Pharmaceuticals, specifying the dates and restrictions for exercising the options [1][2]. Group 1: Stock Option Plan Details - The third exercise period for the reserved stock options will commence on February 8, 2025, and conclude on February 7, 2026 [1]. - The restriction period for exercising the stock options is set from December 22, 2025, to January 5, 2026, during which all incentive recipients will be restricted from exercising their options [1]. Group 2: Compliance and Administration - The company will apply to the China Securities Depository and Clearing Corporation Limited Shanghai Branch for handling matters related to the exercise restrictions in accordance with relevant regulations [2].